Cytoplasmic DDX3 as prognosticator in male breast cancer

Male breast cancer (MBC) is a rare disease. Due to its rarity, treatment is still directed by data mainly extrapolated from female breast cancer (FBC) treatment, despite the fact that it has recently become clear that MBC has its own molecular characteristics. DDX3 is a RNA helicase with tumor suppr...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Pol, Carmen C., Moelans, Cathy B., Manson, Quirine F., Batenburg, Marilot C. T., van der Wall, Elsken, Borel Rinkes, Inne, Verkooijen, Lenny, Raman, Venu, van Diest, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516781/
https://www.ncbi.nlm.nih.gov/pubmed/33974127
http://dx.doi.org/10.1007/s00428-021-03107-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516781/
https://www.ncbi.nlm.nih.gov/pubmed/33974127
http://dx.doi.org/10.1007/s00428-021-03107-4

Ejemplares similares